In addition, in the GBM-cortical assembloid model, CD146-deficient GSC23 cells showed less homogeneous and reduced SOX2 levels compared to CD146-proficient control (Supplementary Fig. 2A–C). This evidence concerns the gene SOX2 and glioblastoma.